









市場行情
/
股票
/
nasdaq-ci
/

Cigna Group

297.310USD

-5.450-1.80%

收盤 09/15, 16:00（美東）報價延遲15分鐘

79.26B總市值

15.80本益比TTM



Cigna Group

297.310

-5.450-1.80%

概覽公司財務分析

Cigna Group 是一家全球性醫療保健公司。該公司擁有兩個增長平臺：Evernorth Health Services 和 Cigna Healthcare。該公司的產品組合解決了整個醫療保健系統的各種挑戰。Evernorth Health Services 包括一系列獨立且協調的健康解決方案和功能，旨在使醫療保健系統能夠幫助人們過上更豐富、更健康的生活。健康計劃、僱主、政府組織和醫療保健提供商與 Evernorth Health Services 合作，解決他們在藥房福利、送藥上門、專業藥房、專業分銷以及護理交付和管理解決方案方面的挑戰。Cigna Healthcare 包括美國醫療保健和國際健康業務，爲客戶和客戶提供全面的醫療和協調解決方案。其其他業務包括公司自有壽險 (COLI) 和公司的清算業務。

公司簡介

公司代碼CI

公司名稱Cigna Group

上市日期Apr 01, 1982

CEOMr. David M. Cordani, CPA

員工數量73500

證券類型Ordinary Share

年結日Apr 01

公司地址900 Cottage Grove Road

城市BLOOMFIELD

上市交易所NYSE Consolidated

國家United States of America

郵編06002

電話18602266000

網址https://www.thecignagroup.com/

公司代碼CI

上市日期Apr 01, 1982

CEOMr. David M. Cordani, CPA

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

64.33K

+18.95%

Ms. Donna F. Zarcone, CPA

Independent Director

26.73K

+2.44%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+2.83%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President, Chief Health Officer and Chief Transformation Officer

17.52K

-1.63%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

6.11K

+11.66%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

6.11K

+11.66%

Ms. Kathleen M. Mazzarella

Independent Director

6.11K

+11.66%

Ms. Kimberly A. Ross

Independent Director

4.51K

+16.47%

Mr. George Kurian

Independent Director

3.78K

+20.32%

名稱

名稱/職務

職務

持股

持股變動

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

64.33K

+18.95%

Ms. Donna F. Zarcone, CPA

Independent Director

26.73K

+2.44%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+2.83%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President, Chief Health Officer and Chief Transformation Officer

17.52K

-1.63%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

6.11K

+11.66%

收入明細

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2018

業務USD

名稱

營收

佔比

Pharmacy revenues

48.63B

0.00%

Network revenues

28.21B

0.00%

Home delivery and specialty revenues

18.94B

0.00%

Other revenues

3.08B

0.00%

Fees and other revenues

1.87B

0.00%

Intercompany eliminations

-1.61B

0.00%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

Pharmacy revenues

48.63B

0.00%

Network revenues

28.21B

0.00%

Home delivery and specialty revenues

18.94B

0.00%

Other revenues

3.08B

0.00%

Fees and other revenues

1.87B

0.00%

Intercompany eliminations

-1.61B

0.00%

股東統計

更新時間: 8月15日週五

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.59%

BlackRock Institutional Trust Company, N.A.

4.65%

State Street Global Advisors (US)

4.59%

MFS Investment Management

4.28%

T. Rowe Price Associates, Inc.

3.71%

其他

73.18%

持股股東

佔比

The Vanguard Group, Inc.

9.59%

BlackRock Institutional Trust Company, N.A.

4.65%

State Street Global Advisors (US)

4.59%

MFS Investment Management

4.28%

T. Rowe Price Associates, Inc.

3.71%

其他

73.18%

股東類型

持股股東

佔比

Investment Advisor

50.59%

Investment Advisor/Hedge Fund

29.00%

Research Firm

2.51%

Hedge Fund

2.38%

Pension Fund

2.33%

Bank and Trust

1.78%

Sovereign Wealth Fund

1.38%

Corporation

1.19%

Individual Investor

0.39%

其他

8.45%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

2945

245.93M

92.13%

-10.11M

2025Q1

2995

251.66M

94.16%

-8.16M

2024Q4

2993

255.45M

93.32%

-4.13M

2024Q3

2931

253.73M

90.72%

-10.03M

2024Q2

2910

254.99M

91.23%

-15.89M

2024Q1

2865

261.02M

89.38%

-14.30M

2023Q4

2815

267.28M

91.36%

-8.83M

2023Q3

2725

267.63M

91.08%

-13.20M

2023Q2

2737

270.13M

91.28%

-8.82M

2023Q1

2710

268.83M

90.70%

-14.56M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

26.02M

9.74%

+45.08K

+0.17%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

13.26M

4.97%

-120.53K

-0.90%

Mar 31, 2025

State Street Global Advisors (US)

12.47M

4.67%

-249.53K

-1.96%

Mar 31, 2025

MFS Investment Management

11.31M

4.23%

+82.46K

+0.73%

Mar 31, 2025

T. Rowe Price Associates, Inc.

11.65M

4.36%

+1.09M

+10.30%

Mar 31, 2025

Dodge & Cox

8.89M

3.33%

+117.13K

+1.34%

Mar 31, 2025

Fidelity Management & Research Company LLC

10.52M

3.94%

+544.14K

+5.45%

Mar 31, 2025

Sanders Capital, LLC

7.99M

2.99%

-65.52K

-0.81%

Mar 31, 2025

Geode Capital Management, L.L.C.

6.04M

2.26%

+79.50K

+1.33%

Mar 31, 2025

GQG Partners, LLC

4.89M

1.83%

+865.09K

+21.51%

Mar 31, 2025

持股ETF

更新時間: 8月6日週三

機構名稱

佔比

iShares U.S. Healthcare Providers ETF

3.99%

VictoryShares Free Cash Flow ETF

3.94%

Invesco Dynamic Buyback Achievers ETF

3.83%

Monarch Dividend Plus Index ETF

2.86%

Fidelity Blue Chip Value ETF

2.75%

VictoryShares US Multi-Factor Minimum Vol ETF

2.59%

Brandes US Value ETF

2.27%

Davis Select US Equity ETF

2.21%

First Trust Health Care Alphadex Fund

2.19%

Bushido Capital US Equity ETF

2.16%

iShares U.S. Healthcare Providers ETF

佔比3.99%

VictoryShares Free Cash Flow ETF

佔比3.94%

Invesco Dynamic Buyback Achievers ETF

佔比3.83%

Monarch Dividend Plus Index ETF

佔比2.86%

Fidelity Blue Chip Value ETF

佔比2.75%

VictoryShares US Multi-Factor Minimum Vol ETF

佔比2.59%

Brandes US Value ETF

佔比2.27%

Davis Select US Equity ETF

佔比2.21%

First Trust Health Care Alphadex Fund

佔比2.19%

Bushido Capital US Equity ETF

佔比2.16%

分紅派息

近5年累計派現 5.74B 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Jan 30, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option

Mar 05, 2025

Mar 20, 2025

Mar 05, 2025

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Jul 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option

Sep 04, 2024

Sep 19, 2024

Sep 04, 2024

Apr 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option

Jun 04, 2024

Jun 20, 2024

Jun 04, 2024

Feb 02, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option

Mar 06, 2024

Mar 21, 2024

Mar 05, 2024

Oct 25, 2023

CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option

Sep 06, 2023

Sep 21, 2023

Sep 05, 2023

Apr 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option

Jun 07, 2023

Jun 22, 2023

Jun 06, 2023

Feb 03, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option

Mar 08, 2023

Mar 23, 2023

Mar 07, 2023

Oct 26, 2022

CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022

Dec 06, 2022

Dec 21, 2022

Dec 05, 2022

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

KeyAI

